Want to join the conversation?
$SYMC's 2Q16 non-GAAP operating margin was 28.1%, up 50 BP from last year and at the high end of the guidance range. Cash flow from operating activities totaled $134MM and capital expenditure was $71MM in 2Q16 and $149MM in 1H16. $SYMC returned $262MM to shareholders during 2Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?